Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 11 Jun 2021 for Infinity Pharmaceuticals, INC., €8,625.
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David W. Beier: trading record in brief
David W. Beier (board member) discloses dealings in 2 companies, chiefly Amgen Inc and Infinity Pharmaceuticals, Inc. The record holds 51 filings, for trades running from 29 April 2008 to 10 June 2021.
No open-market purchase appears, only 13 sales worth €8.2M. Other entries cover 27 share grants and 10 option exercises.
Most recently, on 11 June 2021, the filings show a share grant worth €8,625 in Infinity Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David W. Beier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
3,061 shares@ US$3.43100.0% of flowCommon StockSEC:0001140361-21-020650:0
1 of 1 declaration
